Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses

Recruiting now · Not applicable

Conditions studied: Myopia, Myopia Progression, Juvenile Myopia

In brief

The aim of this study is evaluate and compare the mobility performance of children in daily activities while wearing single vision spectacle lenses (control) versus myopia control spectacle lenses (test).

Key facts

Study ID

NCT07229352

Run by

SightGlass Vision, Inc.

People needed

20

Starts

2026-02-02

Expected to finish

2027-07-01

Last updated by the study team

2026-04-30

Who can join

Age: 6 and older, up to 12. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• A participant is eligible for inclusion in the study if they meet the following criteria:
• Are between the ages of 6 and 12 years of age (inclusive) at the time of informed consent/assent.
• Can achieve a corrected visual acuity of 20/20 best-corrected (or equivalent logMAR).
• Have undergone a self-reported oculo-visual examination within the past two years.
• Have no active ocular disease.
• Are willing and able to adhere to instructions, study procedures, and maintain the appointment schedule.
• Have not previously worn or participated in myopia control contact lenses for more than one month and are not currently undergoing any form of myopia control treatment.
• The subject's parent(s) or legal guardian(s) must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form.

You may not qualify if…

• A participant will be excluded from the study if they meet any of the following conditions:
• Have any systemic disease that affects ocular health.
• Are currently using or have used, within the past 7 days, any systemic or topical medications that may impact ocular health.
• Are currently using or have used any topical ophthalmic agents with anti-muscarinic properties within 7 days prior to enrollment or at any point during the study. This includes, but is not limited to, atropine, scopolamine, pirenzepine, tropicamide, cyclopentolate, and homatropine.
• Have used any oral agents with anti-muscarinic properties for a chronic period (2 months or more) or short-term (within 7 days prior to enrollment). This includes, but is not limited to, gastrointestinal anti-spasmodic medications containing atropine, hyoscyamine, and dicyclomine.
• Have known developmental delays.
• Have participated in another clinical study in the last 7 days

Where it is running

• Midwestern University Arizona College of Optometry — Glendale, Arizona, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.